當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

急需“Sertraline hydrochloride”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

標(biāo)題： 1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men 作者：Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名：Clinical Pharmacology in Drug Development 出版日期：2013 期號(hào)：No.4 卷號(hào)：Vol.2 2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者：Colon-Gonzalez F;Kraft WK. 刊名：Expert Opinion on Drug Metabolism and Toxicology 出版日期：2010 期號(hào)：No.10 卷號(hào)：Vol.6 3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者：Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名：J Clin Pharmacol 出版日期：2011 卷號(hào)：Vol.51 4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者：Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名：Clinical Pharmacology in Drug Development 出版日期：2012 期號(hào)：No.3 卷號(hào)：Vol.1 5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者：Bernardo Rapoport;Teresa Smit 刊名：Expert Opinion on Drug Safety 6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者：Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名：Br J Clin Pharmacol 出版日期：2017 7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者：Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名：The Journal of Clinical Pharmacology 出版日期：2007 期號(hào)：NO.7 卷號(hào)：Vol.47 8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者：Ian N Olver 刊名：Ther Clin Risk Manag 出版日期：2008 期號(hào)：No.2 卷號(hào)：Vol.4   [更多]

標(biāo)題： 1、Comparative Pharmacokinetics of the New Oral Cephalosporins 2、Jiang X, Wang N, Zhang Z J, et al. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.[J]. Arzneimittel-Forschung, 2008, 58(7):363-366. 3、Almeida S, Filipe A, Vallée F, et al. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers.[J]. Arzneimittel-Forschung, 2004, 54(11):757-62. 4、De-Oliveira C, Barrientos-Astigarraga R, De-Moraes M, et al. Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study.[J]. Therapeutic Drug Monitoring, 2001, 23(6):709. 5、Impact of moisture and magnesium stearate functionality on manufacturability of wet granulated metformin tablets 6、The?antipruritic?effect?of?5%?doxepin?cream?in?patients?with?eczematousdermatitis.?Doxepin?Study Group. 7、Photoisomerization of Ionic Liquid Ammonium Cinnamates: One-Pot Synthesis?Isolation of Z-Cinnamic Acids 8、[Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. 9、Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study 10、Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies 備注：將符合的文獻(xiàn)PDF格式打包上傳   [更多]

求期刊DOF（Drugs of the future）2017年第10期的文章   [更多]

任務(wù)描述： 根據(jù)文獻(xiàn)題目等相關(guān)信息，在網(wǎng)上下載準(zhǔn)確的文獻(xiàn)，每篇文獻(xiàn)1元。文獻(xiàn)數(shù)量有2100+篇（分11個(gè)數(shù)據(jù)包），中、英文文獻(xiàn)均有，需要找多個(gè)威客來下載文獻(xiàn)，完成較好者可以接多個(gè)數(shù)據(jù)包。 要求： 1.下載文件類型為PDF，內(nèi)容完整，文件名稱要包含文獻(xiàn)題目。 2. 投稿的用戶自己有下載文獻(xiàn)的資源或途徑，我方不提供文獻(xiàn)庫(kù)的賬號(hào)等 3. 一旦接受此項(xiàng)任務(wù)，不得中途退出   [更多]

標(biāo)題： 1、Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori. 2、Removal ofcysteinylation from an unpaired sulfhydryl in the variable regionof a recombinant monoclonal IgG1 antibody improves homogeneity，stability，and biological activity 3、Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study。 4、Synthesis and biological evaluation of bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors. Lee, Yong Sup; Seo, Seon Hee;Yang, Beom-Seok; Lee, Jae Yeol Archiv der Pharmazie (Weinheim,Germany) Volume 338 Issue 10 Pages 502-505 Journal 2005 5、Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: Synthesis of 18FIressa and related molecular probes. Seimbille, Yann; Phelps, Michael E.; Czernin, Johannes; Silverman, Daniel H. S. Journal of Labelled Compounds & Radiopharmaceuticals Volume 48 Issue 11 Pages 829-843 Journal 2005 6、 Kinetic study of a 2-hydroxypropyl - -cyclodextrin-based formulation of all -trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. Lin HS,Chan SY,Low KS,et al. Journal of Pharmacological Sciences . 2000 7、 Design and in vivo testing of 17-beta estradial -HP beta CD sublingual tablets. Fridriksdottir H,Loftsson T,Gudmundsson JA,et al. Pharmazie . 1996 8、 Hydroxypropyl - -cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity. Muller BW,Brauns U. Journal of Pharmacological Sciences . 1986 9、 Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Loftsson T,Masson M,Sigurdsson HH,et al. Pharmazie . 1998 10、 Effect of 2hydroxypropyl - -cyclodextrin on percutaneous absorption   [更多]

求購(gòu)歐洲藥典EP9.0中關(guān)于腺相關(guān)病毒的章節(jié)內(nèi)容   [更多]

高價(jià)求購(gòu)《預(yù)充式導(dǎo)管沖洗器》相關(guān)信息，內(nèi)容要清晰，價(jià)格好商量。。。。   [更多]

標(biāo)題： 1、Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial 2、Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study 3、Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers 4、Development and in vitro/in vivo evaluation of immediate release perindopril tablets 5、The advantages of combination therapy on hypertension: development of immediate release perindoprilindapamide tablet and assessment of bioequivalence studies 6、Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? - PubMed - NCBI 7、Drug Dev Ind Pharm. 2013 Jul;39(7):996-1004. doi: 10.3109/03639045.2012.689765. Epub 2012 May 25. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Shi Y1, Zou M, An Y, Ji Z, Gao P, Cheng G. 8、Drug Dev Ind Pharm. 2006 Jul;32(6):651-60. Production of an extremly low dose procaterol HCl preparation by fluidized-bed coating method: in vitro and in vivo evaluation. Yu TW1, Chen RR, Gau CS. 9、Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Park JH, Choi HK. Arch Pharm Res. 2015 Jul;38(7):1336-44. doi: 10.1007/s12272-014-0547-6. Epub 2015 Jan 8. 10、Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. Drug Dev Ind Pharm. 2017 Feb;43(2):283-292. doi: 10.1080/03639045.2016.1239627. Epub 2016 Oct 6. 要求：將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

標(biāo)題：重金求購(gòu)Gluconolactone《 USP41-NF36 》的藥典標(biāo)準(zhǔn)一份. 詳細(xì)要求： 需求名稱：Gluconolactone《 USP41-NF36 》的藥典標(biāo)準(zhǔn) 具體要求：《 USP41-NF36 》 要求時(shí)間：請(qǐng)?jiān)?017年12月29日之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]